Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

HBIO holding history

Harvard Bioscience Inc in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HBIO overviewAll 13F holders of HBIOFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of HBIO by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−2,779−100.0%Sold outConverted for a 1-for-10 splitHolders
Q4 202527,792$18.6K<0.1%−468,352−94.4%ReducedHolders
Q3 2025496,144$217.6K<0.1%−630,106−55.9%ReducedHolders
Q2 20251,126,250$499.9K<0.1%−311,558−21.7%ReducedHolders
Q1 20251,437,808$813.9K<0.1%−227,305−13.7%ReducedHolders
Q4 20241,665,113$3.51M<0.1%−50,766−3.0%ReducedHolders
Q3 20241,715,879$4.62M<0.1%−111,769−6.1%ReducedHolders
Q2 20241,827,648$5.21M<0.1%−98,678−5.1%ReducedHolders
Q1 20241,926,326$8.17M<0.1%+6910.0%AddedHolders
Q4 20231,925,635$10.3M<0.1%−8,331−0.4%ReducedHolders
Q3 20231,933,966$8.32M<0.1%+116,337+6.4%AddedHolders
Q2 20231,817,629$9.98M<0.1%+72,496+4.2%AddedHolders
Q1 20231,745,133$7.33M<0.1%+3,985+0.2%AddedHolders
Q4 20221,741,148$4.82M<0.1%−1,271−0.1%ReducedHolders
Q3 20221,742,419$4.46M<0.1%−135,423−7.2%ReducedHolders
Q2 20221,877,842$6.76M<0.1%−2080.0%ReducedHolders
Q1 20221,878,050$11.7M<0.1%−5,548−0.3%ReducedHolders
Q4 20211,883,598$13.3M<0.1%−82,221−4.2%ReducedHolders
Q3 20211,965,819$13.7M<0.1%+10,289+0.5%AddedHolders
Q2 20211,955,530$16.3M<0.1%−19,387−1.0%ReducedHolders
Q1 20211,974,917$10.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.